Torthaí cuardaigh - Forastiere, Arlene A.
- 1 - 20 toradh as 29 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes de réir Forastiere, Arlene A., Weber, Randal S., Trotti, Andy
Foilsithe / Cruthaithe 2015Téacs -
2
Implications of the Oropharyngeal Cancer Epidemic de réir Mroz, Edmund A., Forastiere, Arlene A., Rocco, James W.
Foilsithe / Cruthaithe 2011Téacs -
3
HPV-associated Head and Neck Cancer: A Virus-related Cancer Epidemic – A Review of Epidemiology, Biology, Virus Detection and Issues in Management de réir Marur, Shanthi, D’Souza, Gypsyamber, Westra, William H., Forastiere, Arlene A.
Foilsithe / Cruthaithe 2010Téacs -
4
A phase II trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a tria... de réir Argiris, Athanassios, Ghebremichael, Musie, Burtness, Barbara, Axelrod, Rita S., Deconti, Ronald C., Forastiere, Arlene A.
Foilsithe / Cruthaithe 2011Téacs -
5
Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region de réir Wu, Tsung-Teh, Watanabe, Toshiaki, Heitmiller, Richard, Zahurak, Marianna, Forastiere, Arlene A., Hamilton, Stanley R.
Foilsithe / Cruthaithe 1998Téacs -
6
Impact of Surgeon and Hospital Volume on Short-Term Outcomes and Cost of Oropharyngeal Cancer Surgical Care de réir Gourin, Christine G., Forastiere, Arlene A., Sanguineti, Giuseppe, Marur, Shanthi, Koch, Wayne M., Bristow, Robert E.
Foilsithe / Cruthaithe 2011Téacs -
7
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302... de réir Oswald, Laura B., Lee, Ju‐Whei, Argiris, Athanassios, Webster, Kimberly A., Forastiere, Arlene A., Cella, David
Foilsithe / Cruthaithe 2020Téacs -
8
-
9
Modeling using baseline characteristics in a small multicenter clinical trial for Barrett’s esophagus de réir Shar, Albert O., Gaudard, Marie A., Heath, Elisabeth I., Forastiere, Arlene A., Yang, Vincent W., Sontag, Stephen J.
Foilsithe / Cruthaithe 2008Téacs -
10
-
11
Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial de réir Argiris, Athanassios, Ghebremichael, Musie, Gilbert, Jill, Lee, Ju-Whei, Sachidanandam, Kamakshi, Kolesar, Jill M., Burtness, Barbara, Forastiere, Arlene A.
Foilsithe / Cruthaithe 2013Téacs -
12
Eastern Cooperative Oncology Group (E1201) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in esophageal ade... de réir Kleinberg, Lawrence R., Catalano, Paul, Forastiere, Arlene A., Keller, Steven M., Mitchel, Edith P., Anne, Pramila Rani, Benson, Al B.
Foilsithe / Cruthaithe 2015Téacs -
13
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression i... de réir Gilbert, Jill, Lee, Ju Whei, Argiris, Athanassios, Haigentz, Missak, Feldman, Lawrence Eric, Jang, Minyoung, Arun, Pattatheyil, Van Waes, Carter, Forastiere, Arlene A.
Foilsithe / Cruthaithe 2012Téacs -
14
Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma de réir Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.
Foilsithe / Cruthaithe 2018Téacs -
15
Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303 de réir Psyrri, Amanda, Lee, Ju-Whei, Pectasides, Eirini, Vassilakopoulou, Maria, Kosmidis, Efstratios K., Burtness, Barbara A., Rimm, David L., Wanebo, Harold J., Forastiere, Arlene A.
Foilsithe / Cruthaithe 2014Téacs -
16
Predicting survival in head and neck squamous cell carcinoma from TP53 mutation de réir Masica, David L., Li, Shuli, Douville, Christopher, Manola, Judith, Ferris, Robert L., Burtness, Barbara, Forastiere, Arlene A., Koch, Wayne M., Chung, Christine H., Karchin, Rachel
Foilsithe / Cruthaithe 2014Téacs -
17
Recurrence after Neoadjuvant Chemoradiation and Surgery for Esophageal Cancer: Does the Pattern of Recurrence Differ for Complete Responders and Those with Partial or No response? de réir Meguid, Robert A., Hooker, Craig M., Taylor, Joshua T., Kleinberg, Laurence R., Cattaneo, Stephen M., Sussman, Marc S., Yang, Stephen C., Heitmiller, Richard F., Forastiere, Arlene A., Brock, Malcolm V.
Foilsithe / Cruthaithe 2009Téacs -
18
Secondary Chemoprevention of Barrett’s Esophagus With Celecoxib: Results of a Randomized Trial de réir Heath, Elisabeth I., Canto, Marcia Irene, Piantadosi, Steven, Montgomery, Elizabeth, Weinstein, Wilfred M., Herman, James G., Dannenberg, Andrew J., Yang, Vincent W., Shar, Albert O., Hawk, Ernest, Forastiere, Arlene A.
Foilsithe / Cruthaithe 2007Téacs -
19
Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Re... de réir Rosenthal, David I., Harris, Jonathan, Forastiere, Arlene A., Weber, Randal S., Ridge, John A., Myers, Jeffrey N., Garden, Adam S., Kuettel, Michael R., Sidhu, Kulbir, Schultz, Christopher J., Trotti, Andy, Ang, K. Kian
Foilsithe / Cruthaithe 2009Téacs -
20
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer de réir Forastiere, Arlene A., Zhang, Qiang, Weber, Randal S., Maor, Moshe H., Goepfert, Helmuth, Pajak, Thomas F., Morrison, William, Glisson, Bonnie, Trotti, Andy, Ridge, John A., Thorstad, Wade, Wagner, Henry, Ensley, John F., Cooper, Jay S.
Foilsithe / Cruthaithe 2013Téacs